June 7, 2023
Clinical Case Reports
Faculty of Medicine, Alexandria University (Egypt)
"CONCLUSION
... we included 14 studies with a total of 29 cases, 59% of which were males and 41% were females. Following [COVID-19] vaccination, GBS [Guillain-Barré syndrome] typically appeared 14.4 days later. Most cases developed GBS after receiving the AstraZeneca/Oxford vaccine..."
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
document
adverse events,COVID-19,neurological disorders,vaccines